| | |
Page
|
| |||
Prospectus Supplement
|
| ||||||
| | | | S-ii | | | |
| | | | S-iii | | | |
| | | | S-1 | | | |
| | | | S-5 | | | |
| | | | S-11 | | | |
| | | | S-11 | | | |
| | | | S-12 | | | |
| | | | S-13 | | | |
| | | | S-14 | | | |
| | | | S-16 | | | |
| | | | S-22 | | | |
| | | | S-22 | | | |
| | | | S-22 | | | |
| | | | S-23 | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 3 | | | |
| | | | | 3 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 7 | | | |
| | | | | 9 | | | |
| | | | | 16 | | | |
| | | | | 17 | | | |
| | | | | 18 | | | |
| | | | | 20 | | | |
| | | | | 20 | | | |
| | | | | 20 | | | |
| | | | | 20 | | |
| | |
As of June 30, 2021
|
| |||||||||
|
Actual
|
| |
As Adjusted(1)
|
| ||||||||
|
(in thousands, except share
and per share data) (unaudited) |
| |||||||||||
Cash and cash equivalents
|
| | | $ | 26,118 | | | | | | | | |
Stockholders’ equity: | | | | | | | | | | | | | |
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding, actual or as adjusted
|
| | | | — | | | | | | — | | |
Common stock, $0.0001 par value; 150,000,000 shares authorized, 92,928,205 shares issued and outstanding, actual or shares issued and outstanding as adjusted
|
| | | | 9 | | | | | | | | |
Additional paid-in capital
|
| | | | 371,588 | | | | | | | | |
Accumulated other comprehensive income
|
| | | | — | | | | | | | | |
Accumulated deficit
|
| | | | (346,988) | | | | | | | | |
Total stockholders’ equity
|
| | | | 24,609 | | | | | | | | |
Total capitalization
|
| | | $ | 24,609 | | | | | | | | |
|
Public offering price per share and accompanying warrant
|
| | | | | | | | | $ | | | |
|
Net tangible book value per share at June 30, 2021
|
| | | $ | 0.26 | | | | | | | | |
|
Increase in net tangible book value per share attributable to new investors purchasing securities in this offering
|
| | | | | | | | | | | | |
|
As adjusted net tangible book value per share after this offering
|
| | | | | | | | | | | | |
|
Dilution per share to new investors in this offering
|
| | | | | | | | | $ | | | |
| | |
Per Share and
accompanying Warrant |
| |||
Public offering price
|
| | | $ | | | |
Underwriting discounts and commissions payable by us Proceeds, before expenses, to us
|
| | | $ | | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 3 | | | |
| | | | | 3 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 7 | | | |
| | | | | 9 | | | |
| | | | | 16 | | | |
| | | | | 17 | | | |
| | | | | 18 | | | |
| | | | | 20 | | | |
| | | | | 20 | | | |
| | | | | 20 | | | |
| | | | | 20 | | |